A large segment of the proteome consists of disordered regions, yet in most cases, little is known about their mechanisms and functions. What are the roles of protein disorder in cell biology, and how do intrinsically disordered proteins function? These are the questions Cell's Robert Kruger posed to
Robert Kruger: There's a really rich picture emerging about the functions of intrinsically disordered proteins (IDPs), and I'm curious to hear from you what you find are the most striking or exciting areas that are coming forward about the roles of IDPs in the cell.
Madan Babu: I think [much] of our philosophical thinking about discovering functional elements in protein-encoding regions have been dominated by regions of conservation-if something is functional and important, it's got to be conserved . It's true for a large part of motifs in disordered regions, but then when organisms become different, something must be different between them that allows them to diverge in terms of using the same components but rewiring them differently. I think disordered regions give rise to organism-specific motifs-organism-specific regulatory properties.
RK: And things that can evolve very quickly. MB: Exactly. That, I think, is a very exciting area-any technology or technique that allows you to probe biologically the function of every disordered regional segment.
RK: So what particular functions are you most interested in probing?
MB: For instance, being regulated by different kinases-how quickly can you change the substrate or different kinases? And this essentially means that through different pathways, you could regulate a common set of genes.
RK: What would you guys say about just looking at a sequence of a disordered region? How much you can say about its function, currently?
Julie Forman-Kay: I think that relies on probably two aspects of computational sequence gazing. One of them is looking at the post-translational modifications and other SLiMs (short linear motifs) and picking out those. There's a ton of biology that comes from these small little motifs binding to modular binding domains and also thinking about how post-translational modification changes those. Then there's the overall compositional, ''What does this really look like?'' And if you've got residues that are more highly conserved and that look like they could fold upon binding or fold upon phosphorylation or fold upon something, then you can have some idea. Or if they look [to be of] variable complexity, they could be involved in these phase-separating states or fibrous states. So I think you can get that kind of a rough picture for regulation as function and global binding and bio-material as function.
Richard W. Kriwacki: I agree with Julie that we can identify functional elements. Stepping back a bit, we've been able to identify regions of proteins that are disordered using computational algorithms, but we couldn't read the code within those regions.
So with the identification of short linear motifs, we were able to gain insight into recognition elements and, in many cases, as Julie said, elements that contain sites of post-translational modification, making these elements switches in many cases. Even with growing knowledge of the sequence patterns within short linear motifs, you really don't know how they work together. So in many cases there can be a large number of short linear motifs, but only a small subset will function in interacting with one partner, and another subset may interact with another partner. We don't have the knowledge now to decode the short linear motifs.
But another direction the field has taken more recently is through the recognition that disordered regions within proteins participate in phase separation to form membrane-less organelles. And through the work of Julie and a number of other labs, we're beginning to understand the low-complexity sequence patterns that confer the ability to phase separate. And this is a major advance because a very large proportion of disordered regions encompass these low-complexity sequences.
And this presents a new challenge to decode these patterns and understand which membrane-less organelle a particular protein may participate, or function, within. Because right now . there are subsets with subtly different or sometimes more dramatically different sequence patterns. But we really don't yet understand the relationship between these patterns and the organelles in which they localize, and we understand even less about the functions that are conferred or that are controlled.
JF: I think it's even worse than that. You can make a list of these membrane-less organelles that have been observed by cell biologists for years, but I think that biology can happen in much smaller signaling puncta. I think there are tons of these little structures that concentrate the active elements all over biology, and we have no idea.
MB supramolecular complexes and clusters. What's the difference between two-dimensional phase separation and clustering? . I think that there really isn't a line there-that it's going to be a continuum between self-association at small levels. Bigger, bigger, bigger, bigger, bigger. And then where you start to call it phase separation is probably arbitrary.
RWK: Right. The limits of the structures that form depend upon the amounts of proteins available.
RK: And I imagine for some signaling complexes they can be quite transitory.
RWK: That's one of the brilliant things about these . phase separation as a mechanism for organizing bio-molecules is that the structures are intrinsically dynamic and the interactions that drive their formation are weak and transient and individually the multivalence .
JF: And therefore easy to tune. RWK: One of the big challenges I see now, with this emerging phase separation field, is to understand the relationships between sequences-the structures that form and the functions that are performed within them. We're interested in the nucleolus, and that's where ribosome biogenesis occurs. JF: That's actually a fun thing. So there's all kinds of different ways that people are trying to get at the parts lists of these things, and to see the technological things that are coming out with mass spec approaches or two-photon laser cross-linking experiments. It's an exciting methodological explosion right now.
RWK: I would love to be a graduate student right now. There are so many incredible opportunities spanning the whole continuum-from biophysics, interface with fluid physics, with structural biology, with biochemistry, with biology . What's amazing is to see so many students, graduate students and post docs, absolutely excited about this field right now, really recognize its importance, the open questions, and for them the opportunities.
RK: For those that are starting to realize that this is a field that's growing and that there's a lot of excitement here and that's going to impinge upon their own work, is there something that each of you would want to impart to those people?
MB: I think the key thing would be for them to be bold and apply a multidisciplinary approach rather than stick to a technique or a technology, but really try to link directly the function of the IDP to biology.
RWK: I think maybe another way of looking at it is, almost wherever you look in biology, disordered proteins are playing roles.
RK: They're a huge percentage of the genome. JF: 30% plus of residues. RWK: One way of looking at the range of ways they do this is to think about the organizational levels in which they play their roles. They can play their roles within small multi-component complexes that play extremely important roles in biology. So, for example, cyclin-dependent kinase complexes, which are regulated by a family of disordered proteins. Those are relatively small assemblies that control the transitions between cell cycle.
Then you have molecular machines-for example, what was presented by Jim Hurley. The assemblies involved in regulating the initiation of autophagy. These are assemblies on a larger scale with a dozen or more components, but he's identified that a short disordered region within one protein-within this more-than-a-dozen-component assembly-is responsible for controlling the motions between different subdomains within the assembly. And this is essential for controlling the overall function of the protein.
RK: It seems like that's going to be the norm for all the large molecular machines in the cell.
JF: The way that I would phrase it is that for too long people have had a very strict structure-function paradigm that has controlled their understanding of biology. . And they've also had a paradigm where it's one protein interacting with another protein and a one-to-one interaction in terms of regulation. What they need to understand is that things happen on a continuum. You've got folded proteins that are enzymes that have a core stable structure, but enzymatic function only occurs through dynamics. More and more dynamics are possible all the way out to extreme disorder. And that nature is going to exploit it. Nature's going to take advantage of the physics, and that they have to understand that biology is not separate from physics.
RWK: I was thinking about this earlier as I was mountain biking around Les Diablerets, and you can think about disorder in the context of several different types of continuums. There's this organizational continuum that I was talking about a moment ago. And so beyond these complex multi-component assemblies, then the next sort of transition in the continuum is to structures that arise from phase 
